Site Search
279 Results (showing 1 - 25)
Feb 28, 2002
Appeals Court Affirms Stratagene Victory in Invitrogen Patent Suit
NEW YORK, Feb. 28 - A federal appeals court has handed Stratagene a victory in an ongoing patent dispute sparked by Invitrogen, Stratagene said on Thursday.
Feb 28, 2002
Celera s Tri-Conference Luncheon Serves Up Mouse and E-Commerce
SANTA CLARA, Calif., Feb. 28 - Celera Genomics used the prospect of a free lunch to entice some 160 conference attendees to learn how to use its annotated human and mouse genomes database and tools.
Feb 28, 2002
Orchid Posts Broader Revenue and Widened Loss in Q4; Two Units Eye Black
NEW YORK, Feb. 28 - Orchid BioSciences on Thursday reported a 112 percent jump in fourth-quarter revenue as a significant increase in total expenses fueled a widened net loss.
Feb 28, 2002
For Maynard Olson, It s the (Healthy) Research Subjects, Stupid
SANTA CLARA, Calif., Feb. 28 - Maynard Olson wants to put the "H" back into the National Institutes of Health.
Feb 27, 2002
BIOINFORM SUBSCRIBERS: BioSilico 2002 Raises More Questions than Answers for Future of In Silico Biology
This article is available to subscribers of BioInform.
Feb 27, 2002
BioDiscovery, Genops Ink Plan to Integrate IT Platforms
NEW YORK, Feb. 27 - BioDiscovery and Genops Bioinformatics have announced plans to integrate their platform products.
Feb 27, 2002
PEOPLE: GenomeWeb s Weekly Personnel Roundup of the Genomics Sector: Feb 27, 2002
NEW YORK, Feb.
Feb 27, 2002
Crafty Genomic Shoehorn May Yield Warp-Speed Whole-Genome Sequencing
SANTA CLARA, Calif., Feb.
Feb 27, 2002
Caprion Taps McGill University to Help Expand Its Proteomics Effort
NEW YORK, Feb. 27 - Caprion Pharmaceuticals has asked neighboring McGill University to help expand its proteomics research, the company said on Wednesday.
Feb 27, 2002
EXCLUSIVE: Ousted Paradigm Chief Says He May Sue Board
NEW YORK, Feb. 27 - Ousted Paradigm Genetics president and CEO John Ryals said he may "take legal action" against Paradigm's board, he told GenomeWeb in an interview on Wednesday.
Feb 27, 2002
OGS-Marconi JV Debuts Its Protein Atlas. But Customers Will Have to Wait Til June
SANTA CLARA, Calif., Feb. 27 - The Protein Atlas is a bit of a June bug.
Feb 27, 2002
Orchid BioSciences Pockets $20M in Stock Offering
NEW YORK, Feb. 27 - Orchid BioSciences on Wednesday said it has pocketed approximately $20 million in a special stock offering announced last week.
Feb 27, 2002
SBI, Quest Say Novel IT Can Help Predict Resistance to HIV Drugs
NEW YORK, Feb. 27 - Structural Bioinformatics said it has come up with a novel computational method that may help predict patients' resistance to protease inhibitors.
Feb 27, 2002
UPDATE: Paradigm Genetics Sacks CEO, President Ryals
NEW YORK, Feb. 27 - Paradigm Genetics has fired its CEO and President John A. Ryals and has appointed Chief Scientific Officer John E. Hamer to take the helm while a "global search is conducted.
Feb 26, 2002
UPDATE: Pyrosequencing Opens Sales Office in California
NEW YORK, Feb. 26 - Pyrosequencing on Tuesday said it has opened a facility in California.
Feb 26, 2002
Third Wave s Net Loss Balloons in Q4 as Sales Decline and R&D Costs Surge
NEW YORK, Feb. 26 - Third Wave on Tuesday reported that a decline in product sales and a significant jump in R&D spending in the fourth quarter helped cause total revenue to fall slightly and net loss to balloon.
Feb 26, 2002
Amersham, ABI End Patent Battles; Firms Will Cross-License Products Instead
Amersham and Applied Biosystems early on Tuesday said they have called a truce to their ongoing patent-infringement court battle.
Feb 26, 2002
Variagenics Posts Miniscule Revenue, Widened Loss in Q4
NEW YORK, Feb. 26 - Variagenics on Tuesday said that a significant drop in fourth-quarter total revenue conspired with increased R&D costs to send net loss spiraling skyward.
Feb 26, 2002
Paradigm Genetics Sacks CEO and President Ryals
For an updated version of this story, click
Feb 26, 2002
Novel Study Uses Genomics Tools to Link Alleles With Response to Anesthesia
SANTA CLARA, Calif., Feb.